Tom Carper

We are asking for a very specific carve-out for a very small exception that does not necessarily--well, it does not cost us any money.

I am proud of the FDA's 'Gold Standard.' I am proud of what the FDA does.

I appreciate the intent of Senator Johnson's bill--I think we all do--and I, certainly, support expanding access to experimental therapies for terminally ill patients.

I appreciate your willingness to continue a conversation about what we all know is an important issue that is critical for Americans seeking access to potentially lifesaving treatment.

If my Democratic colleagues and other Republican colleagues that have not cosponsored it are not willing to cosponsor it, please do not object so we can pass this bill and so we can give these patients and their families the right to hope.

And, I just want to say, to those of you who continue to lead a good fight... thank you. You are doing the Lord's work.

I think that it would be terrific if Congress could pass the Andrea Sloan CURE Act to start improving the compassionate use process.

We need to reauthorize the Creating Hope Act.

We want them to promote health.

We all need to love the FDA, and not do fire-alarm, knee-jerk oversight.

The compassionate use process needs to be expedited.

We want you to use the tools that we have already given you. This is legislation that already exists.

In 2012, when the President signed FDASIA, that had a lot of support.

What do you think that those of us who are sitting over here on this side of the dais can do, either through legislation or, maybe, through partnering with the Administration, to improve patient access to new treatments or to new therapies?

So, I just want to provide this as an example of how, from my perspective, I think, the goal is to create reasons for companies to start pediatric trials--get the denominator as big as possible.

We are 25 years behind.

You should not have to beg the Federal Government for permission to save your life.

What actions do you think that Congress should take--that Senator Johnson and myself and our colleagues should take--either through legislation or through partnering with the administration, to improve patient access to new and potentially…

One concern that I think that we are hearing here, today, is about a lack of access to information about which programs are available to help people who are facing these life-threatening conditions.

That is over half of all of the drugs?

Thank you for bringing this together this morning.

I am fully supportive of 'Right to Try.'

We must work together to find solutions that benefit all Americans.

I think it was 2005 when Congress and President George W. Bush got together and enacted the RFS legislation for a couple of reasons: one, to diversify our Nation's energy portfolio; second, to strengthen the economy, particularly the…

Find out what works and do more of that.